Allogene Therapeutics Reports Second Quarter 2022 Financial Results

Go back to Allogene Therapeutics Reports Second Quarter 2022 Financial Results
(NASDAQ: ALLO) Delayed: 2.05 -0.04 (1.91%)
Previous Close $2.09    52 Week High
Open $2.11    52 Week Low
Day High $2.11    P/E N/A 
Day Low $2.00    EPS
Volume 1,905,289